AMERICAN ACADEMY OF NEUROLOGY: USE OF ACID REFLUX DRUGS LINKED TO HIGHER RISK OF MIGRAINE
April 26, 2024
April 26, 2024
MINNEAPOLIS, Minnesota, April 26 (TNSres) -- The American Academy of Neurology issued the following news release:
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology(R)Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omepraz . . .
People who take acid-reducing drugs may have a higher risk of migraine and other severe headache than people who do not take these medications, according to a study published in the April 24, 2024, online issue of Neurology(R)Clinical Practice, an official journal of the American Academy of Neurology. The acid-reducing drugs include proton pump inhibitors such as omepraz . . .